Brexpiprazole for the Treatment of Co-occurring Schizophrenia and Substance Use Disorder
The Journal of Clinical Psychiatry · 2025
DOI: 10.4088/jcp.25m15786 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Psychiatry, 2025. Verfasst von Xiaoduo Fan und 4 weiteren Autor:innen. Beteiligte Einrichtung: UMass Mind Clinical and Research Program, UMass Memorial Health/University of Massachusetts Chan Medical School, Worcester, Massachusetts. Hauptthemen laut MEDLINE: Schizophrenia, Quinolones, Thiophenes, Substance-Related Disorders.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- UMass Mind Clinical and Research Program, UMass Memorial Health/University of Massachusetts Chan Medical School, Worcester, Massachusetts.
- Corresponding Author: Xiaoduo Fan, MD, MPH, UMass Memorial Health/University of Massachusetts Chan Medical School, Medical School Building S3-432, 55 Lake Ave North, Worcester, MA 01655 (xiaoduo.fan@umassmed.edu).
- Psychosis Clinical and Research Program, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts.
- North Carolina Psychiatric Research Center, Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
- Department of Psychiatry, Augusta University, Augusta, Georgia.
Zitieren
APA
Fan, X., Freudenreich, O., Jarskog, L. F., McEvoy, J., & Harrington, A. (2025). Brexpiprazole for the Treatment of Co-occurring Schizophrenia and Substance Use Disorder. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.25m15786
Vancouver
Fan X, Freudenreich O, Jarskog LF, McEvoy J, Harrington A. Brexpiprazole for the Treatment of Co-occurring Schizophrenia and Substance Use Disorder. The Journal of Clinical Psychiatry. 2025. doi:10.4088/jcp.25m15786
BibTeX
@article{Fan2025,
author = {Fan, Xiaoduo and Freudenreich, Oliver and Jarskog, L Fredrik and McEvoy, Joseph and Harrington, Amy},
title = {Brexpiprazole for the Treatment of Co-occurring Schizophrenia and Substance Use Disorder},
journal = {The Journal of Clinical Psychiatry},
year = {2025},
doi = {10.4088/jcp.25m15786}
}
EUVIMED